Concepedia
Publication | Open Access
The Novel Triple Reuptake Inhibitor JZAD-IV-22 Exhibits an Antidepressant Pharmacological Profile without Locomotor Stimulant or Sensitization Properties
26
Citations
22
References
2010
Year
Page 1